0 followers
Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them.
Industries
Headquarters
Employees
Links
Ward Peterson
4 members
3 members
2 members
Bio-Rad Laboratories
11 followers
BioMarin Pharmaceutical
21 followers
Adaptive Biotechnologies
Agilent Technologies
60 followers
Regeneron
77 followers
Discover companies